Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Equity (2016 - 2025)

Historic Return on Equity for Nephros (NEPH) over the last 15 years, with Q3 2025 value amounting to 0.15%.

  • Nephros' Return on Equity rose 2700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.01% for FY2024, which is 1900.0% up from last year.
  • Latest data reveals that Nephros reported Return on Equity of 0.15% as of Q3 2025, which was up 2700.0% from 0.14% recorded in Q2 2025.
  • Over the past 5 years, Nephros' Return on Equity peaked at 0.15% during Q3 2025, and registered a low of 0.31% during Q2 2023.
  • For the 5-year period, Nephros' Return on Equity averaged around 0.14%, with its median value being 0.17% (2024).
  • Per our database at Business Quant, Nephros' Return on Equity plummeted by -2000bps in 2023 and then soared by 3000bps in 2025.
  • Nephros' Return on Equity (Quarter) stood at 0.19% in 2021, then crashed by -63bps to 0.31% in 2022, then soared by 41bps to 0.18% in 2023, then surged by 105bps to 0.01% in 2024, then surged by 1481bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.14% for Q2 2025, and 0.09% during Q1 2025.